the benefits of glp-1 drugs beyond obesity Unstoppable Rise Agonists: Revolutionising Diabetes and Treatment Popular GLP-1 medications may have

Preventing the progression of diabetic kidney disease Multimorbidity is common in people with DKD and, therefore, there is an increasing emphasis on comprehensive, holistic medical care to improve overall patient outcomes

Current clinical guidance focuses primarily on managing gastrointestinal side effects during GLP-1RA treatment, with some nutrition considerations recommended based on previous literature in weight loss science [[7], [8], [9], [10], [11]]

I 2 = 27%) compared with metformin, but not for HbA1c (MD: -0.05, 95% CI: -0.19, 0.09

As shown in Scheme 8

Keum, N

Hepatology 2006;43:173-81.ArticlePubMedPMC 37